BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28125174)

  • 1. Pharmacologic Treatments for Binge-Eating Disorder.
    McElroy SL
    J Clin Psychiatry; 2017; 78 Suppl 1():14-19. PubMed ID: 28125174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice.
    Amodeo G; Cuomo A; Bolognesi S; Goracci A; Trusso MA; Piccinni A; Neal SM; Baldini I; Federico E; Taddeucci C; Fagiolini A
    Expert Opin Pharmacother; 2019 Apr; 20(6):679-690. PubMed ID: 30696303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In brief: lisdexamfetamine (Vyvanse) for binge eating disorder.
    Med Lett Drugs Ther; 2015 Mar; 57(1464):42. PubMed ID: 25758546
    [No Abstract]   [Full Text] [Related]  

  • 4. Lisdexamfetamine: A Review in Binge Eating Disorder.
    Heo YA; Duggan ST
    CNS Drugs; 2017 Nov; 31(11):1015-1022. PubMed ID: 29134566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA.
    Ágh T; Pawaskar M; Nagy B; Lachaine J; Vokó Z
    Clin Drug Investig; 2016 Apr; 36(4):305-12. PubMed ID: 26914658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.
    Brownley KA; Berkman ND; Peat CM; Lohr KN; Cullen KE; Bann CM; Bulik CM
    Ann Intern Med; 2016 Sep; 165(6):409-20. PubMed ID: 27367316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial.
    Hudson JI; McElroy SL; Ferreira-Cornwell MC; Radewonuk J; Gasior M
    JAMA Psychiatry; 2017 Sep; 74(9):903-910. PubMed ID: 28700805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of binge eating disorder.
    Wilson GT
    Psychiatr Clin North Am; 2011 Dec; 34(4):773-83. PubMed ID: 22098803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Treatments for Binge-Eating Disorder: Systematic Review and Network Meta-Analysis.
    Peat CM; Berkman ND; Lohr KN; Brownley KA; Bann CM; Cullen K; Quattlebaum MJ; Bulik CM
    Eur Eat Disord Rev; 2017 Sep; 25(5):317-328. PubMed ID: 28467032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binge Eating Disorder.
    Guerdjikova AI; Mori N; Casuto LS; McElroy SL
    Psychiatr Clin North Am; 2017 Jun; 40(2):255-266. PubMed ID: 28477651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2015 Apr; 69(4):410-21. PubMed ID: 25752762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials.
    McElroy SL; Hudson J; Ferreira-Cornwell MC; Radewonuk J; Whitaker T; Gasior M
    Neuropsychopharmacology; 2016 Apr; 41(5):1251-60. PubMed ID: 26346638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lisdexamfetamine in Pediatric Binge Eating Disorder: A Retrospective Chart Review.
    Guerdjikova AI; Blom TJ; Mori N; Matthews A; Cummings T; Casuto LL; McElroy SL
    Clin Neuropharmacol; 2019; 42(6):214-216. PubMed ID: 31725476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial.
    Guerdjikova AI; Mori N; Blom TJ; Keck PE; Williams SL; Welge JA; McElroy SL
    Hum Psychopharmacol; 2016 Sep; 31(5):382-91. PubMed ID: 27650406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of binge eating disorder: update review and synthesis.
    Reas DL; Grilo CM
    Expert Opin Pharmacother; 2015; 16(10):1463-78. PubMed ID: 26044518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder.
    McElroy SL; Hudson JI; Gasior M; Herman BK; Radewonuk J; Wilfley D; Busner J
    Int J Eat Disord; 2017 Aug; 50(8):884-892. PubMed ID: 28481434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining Pharmacological and Psychological Treatments for Binge Eating Disorder: Current Status, Limitations, and Future Directions.
    Grilo CM; Reas DL; Mitchell JE
    Curr Psychiatry Rep; 2016 Jun; 18(6):55. PubMed ID: 27086316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacologic treatment of eating disorders: emerging findings.
    McElroy SL; Guerdjikova AI; Mori N; Keck PE
    Curr Psychiatry Rep; 2015 May; 17(5):35. PubMed ID: 25796197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lisdexamfetamine Dimesylate Effects on Binge Eating Behaviour and Obsessive-Compulsive and Impulsive Features in Adults with Binge Eating Disorder.
    McElroy SL; Mitchell JE; Wilfley D; Gasior M; Ferreira-Cornwell MC; McKay M; Wang J; Whitaker T; Hudson JI
    Eur Eat Disord Rev; 2016 May; 24(3):223-31. PubMed ID: 26621156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic Treatment of Eating Disorders.
    Crow SJ
    Psychiatr Clin North Am; 2019 Jun; 42(2):253-262. PubMed ID: 31046927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.